RIZZOLIO, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.114
AS - Asia 7.547
EU - Europa 7.123
SA - Sud America 907
AF - Africa 153
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 17
Totale 35.880
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.733
CN - Cina 3.246
SG - Singapore 2.296
IT - Italia 1.960
PL - Polonia 1.494
BR - Brasile 787
HK - Hong Kong 705
IE - Irlanda 652
DE - Germania 650
UA - Ucraina 544
SE - Svezia 457
GB - Regno Unito 385
CA - Canada 307
RU - Federazione Russa 259
VN - Vietnam 255
IN - India 232
FR - Francia 216
JP - Giappone 177
TR - Turchia 164
FI - Finlandia 127
KR - Corea 110
AT - Austria 85
ID - Indonesia 84
ES - Italia 72
MX - Messico 57
BD - Bangladesh 54
NL - Olanda 53
BE - Belgio 47
ZA - Sudafrica 46
IR - Iran 40
PK - Pakistan 40
EC - Ecuador 36
AR - Argentina 34
BJ - Benin 33
IQ - Iraq 31
CH - Svizzera 28
UZ - Uzbekistan 24
MA - Marocco 23
EU - Europa 17
GR - Grecia 14
AU - Australia 13
CL - Cile 13
BG - Bulgaria 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 10
CO - Colombia 10
CZ - Repubblica Ceca 10
PH - Filippine 10
PT - Portogallo 10
JO - Giordania 9
KE - Kenya 9
TH - Thailandia 9
RO - Romania 8
DK - Danimarca 7
DZ - Algeria 7
EG - Egitto 7
LT - Lituania 7
SA - Arabia Saudita 6
AL - Albania 5
DO - Repubblica Dominicana 5
IL - Israele 5
PY - Paraguay 5
SI - Slovenia 5
AM - Armenia 4
KZ - Kazakistan 4
LR - Liberia 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
BO - Bolivia 3
ET - Etiopia 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
TN - Tunisia 3
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DM - Dominica 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
MU - Mauritius 2
OM - Oman 2
QA - Qatar 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
BF - Burkina Faso 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
GD - Grenada 1
Totale 35.855
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.154
Fairfield 2.164
Ashburn 1.936
Warsaw 1.482
Chandler 1.391
Singapore 1.228
Ann Arbor 1.154
Houston 1.143
Dallas 1.018
Seattle 953
Jacksonville 858
Cambridge 717
Hong Kong 704
Wilmington 677
Dublin 585
Beijing 316
Jinan 316
Mestre 284
New York 279
Boardman 265
Venice 265
Nanjing 257
Dearborn 228
Shenyang 223
Council Bluffs 205
Venezia 196
Guangzhou 190
Andover 184
Boston 169
Hefei 159
San Mateo 151
Mülheim 149
Los Angeles 144
Hebei 139
The Dalles 138
Izmir 129
Princeton 129
Toronto 125
Ottawa 119
Munich 114
San Diego 108
Seoul 99
Hangzhou 97
Tianjin 95
Zhengzhou 94
Changsha 92
Columbus 89
São Paulo 89
Nanchang 87
Tokyo 86
Bengaluru 84
Taizhou 83
Altamura 81
Santa Clara 81
Ho Chi Minh City 80
Milan 78
Haikou 77
Jakarta 72
Padova 72
Taiyuan 71
Ningbo 60
London 57
Frankfurt am Main 54
Hanoi 53
Jiaxing 53
Vienna 53
Buffalo 51
San Paolo di Civitate 50
Brussels 45
Redondo Beach 45
Chicago 44
Moscow 43
Redwood City 42
Nuremberg 41
Pune 37
Fuzhou 36
Brooklyn 34
Des Moines 34
North Bergen 34
Cotonou 33
Helsinki 32
Menlo Park 31
Johannesburg 30
Saint Petersburg 28
Latiano 26
Montreal 26
Phoenix 26
Washington 24
Denver 23
Kunming 23
Orem 22
Rio de Janeiro 22
Turku 22
Verona 22
Bremen 21
Rome 21
Chennai 20
Dong Ket 20
Shanghai 20
Bologna 19
Totale 27.129
Salva come PNG Salva come JPEG
Nome #
Bottom-Up Synthesis of Carbon Nanoparticles with Higher Doxorubicin Efficacy 572
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer 531
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? 475
Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications 458
Highly conserved non-coding sequences and the 18q critical region for short stature: A common mechanism of disease? 449
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activity on human ovarian cancer cell lines 421
pRb controls estrogen receptor alpha protein stability and activity 418
A guide to PIN1 function and mutations across cancers 406
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 402
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients 401
Hyaluronan esters drive smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 400
Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer Cells 398
The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine 397
Carbon-dots from sugars and ascorbic acid: Role of the precursors on morphology, properties, toxicity and drug uptake 393
Phamacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer 390
Palladacyclopentadienyl complexes bearing purine-based N-heterocyclic carbenes: A new class of promising antiproliferative agents against human ovarian cancer 389
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor 374
DNA nanotechnology for cancer therapy 372
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 366
An effective multi-stage liposomal DNA origami nanosystem for in vivo cancer therapy 366
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 361
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer 359
The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer 359
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research 356
Self-Therapeutic Nanomaterials for Cancer Therapy: A Review 346
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer 345
Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands 343
Recent advances of electrochemical and optical enzyme-free glucose sensors operating at physiological conditions 340
Androgen receptor serine 81 mediates Pin1 interaction and activity 334
Glucose Detection Devices and Methods Based on Metal–Organic Frameworks and Related Materials 329
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin 326
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 319
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) 312
Adenosine receptor ligands in clinical trials 299
MTHFR-1298 A > C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 295
Highly Selective Salicylketoxime-Based Estrogen Receptor beta Agonists Display Antiproliferative Activities in a Glioma Model 293
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 293
Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines 286
Identification and characterization of a new reversible MAGL inhibitor 285
A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males 285
The Clinical translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes 283
Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 281
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 278
A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28 278
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 277
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 276
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin 275
Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells 274
Epigenetic analysis of the critical region I for premature ovarian failure: Demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome 274
Chromosomal rearrangements in Xq and premature ovarian failure: Mapping of 25 new cases and review of the literature 270
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors 269
Improved Synthesis, Anticancer Activity and Electrochemical Characterization of Unusual Zwitterionic Palladium Compounds with a Ten‐Term Coordinative Ring 269
Allyl palladium complexes bearing carbohydrate-based N-heterocyclic carbenes: Anticancer agents for selective and potent in vitro cytotoxicity 269
Supercritical CO2 extraction of natural antibacterials from low value weeds and agro-waste 268
Pin1 and nuclear receptors: A new language? 267
RB gene family: Genome-wide ChIP approaches could open undiscovered roads 265
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 264
Cyclic Ketoximes as Estrogen Receptor Selective Agonists 262
Fluorescent carbon nanoparticles in medicine for cancer therapy 260
CDK inhibitors: from the bench to clinical trials 258
Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls 258
Critical choices for modeling breast cancer in transgenic mouse models 253
Metabolomics biomarkers of frailty in elderly breast cancer patients 253
Dissecting Pin1 and phospho-pRb regulation 251
Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: A hypothesis 251
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 251
Spatial and temporal expression of POF1B, a gene expressed in epithelia 250
Pharmaco-metabolomics: An emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets 249
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 248
Synthesis and Antimicrobial Evaluation of Bis-morpholine Triazine Quaternary Ammonium Salts 243
Palladium(II)-η3-Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer Tumoroids 242
Nanomedicine in cancer pathology 241
X chromosome and ovarian failure 240
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models 239
Upconversion-mediated Boltzmann thermometry in double-layered Bi2SiO5:Yb3+,Tm3+@SiO2hollow nanoparticles 239
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors 238
Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt's lymphoma cell lines 237
Fluorescent molecularly imprinted nanogels for the detection of anticancer drugs in human plasma 237
Emerging molecular networks in Burkitt's lymphoma 235
Identification of new fyn kinase inhibitors using a FLAP-based approach 234
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 234
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors 229
Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells 226
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 226
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer 221
Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update 221
Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease 220
Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B 219
STARD3: A Prospective Target for Cancer Therapy 215
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer 211
2D metal azolate framework as nanozyme for amperometric detection of glucose at physiological pH and alkaline medium 210
Cancer extracellular vesicles: Next-generation diagnostic and drug delivery nanotools 207
Research highlights. Overcoming BRAF resistance to PLX4032 by AKT inhibition in PTEN-deficient melanoma cells 205
Inorganic Nanoparticles for Cancer Therapy: a Transition from Lab to Clinic 205
Application of MM-PBSA methods in virtual screening 203
Research highlights. Protein kinase D3 is the genetic sensitizer of RAF inhibitor RAF265 in melanoma cells 200
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2NS) for Ovarian Cancer Therapy 199
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer 198
Sustainable triazine-derived quaternary ammonium salts as antimicrobial agents 195
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors 194
Totale 29.387
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.161
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.192 0 0 0 0 0 410 415 396 288 598 663 422
2021/20225.040 344 591 330 625 383 40 221 194 97 740 1.014 461
2022/20233.883 297 384 68 445 366 1.110 50 284 482 32 291 74
2023/20241.937 103 110 72 91 261 443 63 124 216 48 190 216
2024/20253.755 59 98 262 280 299 228 441 398 446 425 546 273
2025/20266.257 961 736 1.707 976 1.597 280 0 0 0 0 0 0
Totale 36.567